Jakafi is a preferred treatment for myelofibrosis
Myelofibrosis is a type of bone marrow cancer that leads to the formation of fibrous tissue in the bone marrow and results in scarring, which impairs the normal production of blood cells. The exact cause of myelofibrosis is unknown, but it is believed to be caused by genetic mutations in the blood cells. Jakafi (ruxolitinib) […]
February is American Heart Month
Each month the Office of Disease Prevention and Health Promotion (part of the US Department of Health and Human Services) selects National Health Observances (NHOs) that highlight issues affecting health across the nation. One of the highlights in February is heart health. The National Heart, Lung, and Blood Institute (NHLBI) sponsors American Heart Month each […]
FDA approves a new type 2 diabetes drug that works in combination with Metformin
On January 20th, the FDA announced approval of a new sodium-glucose cotransporter 2 (SGLT2) inhibitor for treatment of type 2 diabetes in adults. The new drug is produced by Theracos, a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The drug will be marketed under the name Brenzavvy (generic name: bexagliflozin). The […]
Hospital wards in crisis due to infections
What is now being reported as a “tripledemic of Covid, RSV and flu” is pushing U.S. hospitals into a crisis mode. A few months back, we reported on the observations coming from Southern Hemisphere countries like Australia and New Zealand that “Flu is coming early this year”, and even earlier that “there could be a […]
What are the side effects of semaglutide in Ozempic and Wegovy?
Semaglutide is one of the ‘wonder drugs’ that revolutionized the treatment of adults suffering from type 2 diabetes and then went on to become a popular option for patients looking to lose weight. Like all drugs, there can be risk factors that result in side effects of semaglutide. Semaglutide belongs to a class of drugs […]
News coming out of November’s ObesityWeek
The opening week of November saw a flood of news at ObesityWeek regarding progress that has been made in the fight against obesity. Some of the discussions concerned social and economic changes that the gathering of specialists in this area is calling for, and many more items dealt with progress that has been made, and […]
Introducing the new once-a-day pill for Type 2 diabetes that replaces weekly injections
In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide. Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can […]
November is National Diabetes Month
November is National Diabetes Month. In 2022, the theme is sharing ways you can work with health care professionals to build a team to help you manage your diabetes. The Center for Disease Control and Prevention lists some of the most common dangers that come with diabetes as: Heart disease and stroke. People with diabetes […]
World Alzheimer’s Day – September 21st
Each September, organizations all around the world join forces to host memory walks, fundraisers, and campaigns to raise awareness about the millions of people in the general community that are affected by Alzheimer’s Disease or other types of dementia. The peak of activity during the month is World Alzheimer’s Day, which this year is on […]
Do you qualify for use of the latest weight-loss wonder Ozempic?
Visit our Ozempic website page to find out if you now qualify to receive this remarkable new treatment that promotes weight loss. There has been a tremendous revolution in the approach that you can now take to help fight obesity. It started when the use of a weekly injectable drug for type II diabetics called […]
